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Human Gene 
Symbol 
 (Localization) Potentially Regulated by Potentially Regulates
Cellular and 
 Developmental Roles  Mutant Mouse Phenotype
Role in Cancer/­
Human Disease
FOXJ1 (17q25.1) FOXD1, bleomycin IFNG, IL2, NFKBIB, NFkB, 
protein-DNA
 T-lymphocyte proliferation. Random determination of left-right 
asymmetry, no cilia, growth failure, 
hydrocephalus. Die perinatally. 
FOXJ2 
(12p13.31)
FOXJ3 (1p34.1)
FOXK1 (7p22.1) Regulates cell cycle progression 
in myogenic progenitor cells.
Atrophic skeletal muscles, impaired 
satellite cell function.
FOXK2 (17q25.3)
FOXL1 (16q24.1) 2,4-dinitrophenol-ovalbumin 
conjugate, LPS, GLI1, TAC1, 
Hedgehog
proteoglycan, SDC1, BMP2, 
BMP4
Involved in proteoglycan bio-
synthesis. 
Gastric mucosa hyperplasia, sup-
pressed gastric acid secretion.
Mesenchymal modifier 
of APC/Min in gastro-
intestinal carcinogenesis. 
FOXL2 (3q22.3) GDF9, INHBA, AMH Granulosa cell differentiation; de-
velopment of ovarian follicle.
Eyelid and forehead dysmorphology; 
gonadal dysgenesis or premature 
ovarian failure in females. High rate 
of perinatal mortality.
Associated with Blepha-
rophimosis-Ptosis-Epi-
canthus Inversus (BPES); 
Premature ovarian failure.
FOXM1 
(12p13.33)
GLI1, doxorubicin, NRAS, ful-
vestrant, butyric acid, FGF7, 
CDKN1A, YY1, MSA, vitamin 
D3, TNFSF11, IL6, CDC2
CDC25B, CENPA, AURKB, 
CCNA2, CCNF, CENPB, 
BIRC5, CCNB1, CDKN1A, 
ESR1, ADAM17, GLB1
Controls progression into 
S phase; regulates genes 
required for mitotic entry; liver 
 development. 
Reduced hepatoblast and car-
diomyocyte mitosis, ventricular 
hypoplasia. Die perinatally. 
Upregulated in 
 pancreatic cancer.
FOXN1 (17q11.2) WNT5B, WNT4, BMP4, 
Noggin
FAM57A, SERPINB1, GZMA, 
MREG, IL7, TRG, PPP1R16B, 
C19ORF28, CD274, IVL
Epithelial cell proliferation; 
 keratinocyte differentiation; hair 
follicle and thymus development. 
Hairless, abnormal thymus and T cell 
development. Premature death. 
Associated with immuno-
deficiency, alopecia, nail 
dystrophy.
FOXN2  
(2p22-p16)
Upregulation associated 
with advanced papillary 
serous ovarian carcinoma 
in humans.
FOXN3 
(14q24.3-q31)
INSR, STK11, camptothecin, 
ER, MEN1
Involved in G2/M phase of cell 
cycle.
Recruits SKIP to repress 
genes important for 
tumorigenesis.
FOXN4 
(12q24.12)
NEUROD4, NEUROD1, PROX1 Neuron fate commitment, ama-
crine and horizontal cell genesis.
Disrupts commitment of retinal 
progenitors. Die postnatally.
FOXO1 
(13q14.11)
Akt, IGF1, LY294002, Insulin, 
IRS1, IRS2, wortmannin, 
PTEN, INS, PDPK1, IL6, 
FOXO1A, C5b9, TNF
PCK1, BCL2L11, IGFBP1, 
CDKN1B, FASLG, SERPINE1, 
TNFSF10, CXCR4, CCNG2, 
GADD45A, PRL, MYOD1, 
BCL2L1
Mediates insulin signaling, 
suppresses proliferation and/or 
induces apoptosis; development 
of blood vessels, diaphragm, 
and yolk sac.
Incomplete vascular development. 
Die by E10.5. Heterozygotes display 
decreased hepatic glycogen levels.
Fused to PAX3 or PAX7 
in rhabdomyosarcoma.
FOXO2 (1p34.1)
FOXO3 (6q21) Akt, LY294002, IGF1, 
hydrogen peroxide, PI3K, 
EPO, TP53, Pi3 Kinase, 
SGK, IKBKB, CHUK, SHC1, 
etoposide, IL3
BCL2L11, CDKN1B, CCNG2, 
FASLG, FBXO32, CDKN1A, 
RBL2, GADD45A, FOXO3A, 
BNIP3L, SOD2, NOS2A, 
BBC3, HBP1
Differentiation of erythrocytes; 
suppresses spontaneous T cell 
activation and autoimmunity; 
suppresses proliferation and/or 
induces apoptosis. 
Females have follicular activation 
leading to oocyte death and sterility. 
Fused to MLL gene 
in secondary acute 
 myeloblastic leukemia.
FOXO4 (Xq13.1) IGF1, JINK1/2, MAPK10, 
MAPK8, RALA, wortmannin, 
Akt, RGL2, LY294002, RAL-
GPS1, Ras, naltrindole, INS1
CDKN1B, CDKN1A, VEGFA, 
BCL6, RBL2, CDC42EP3, 
LEMD3, GADD45B, SGK, 
OVOL1, EPO, GADD45A, 
CTGF, JAG1, IER3
Negative regulation of cell pro-
liferation; cell-cycle progression; 
cell differentiation. 
Fused to MLL gene 
in acute lymphocytic 
leukemia.
FOXP1 (3p14.1) ITGAM, AGN194204, PMA, 
FOXP1
 Inhibits macrophage differentia-
tion; differentiation of cardiomyo-
cytes; heart development.
Defects in cardiac morphogenesis. 
Die at E14.
May function as tumor 
suppressor.
FOXP2 (7q31) En, GATA6, FOXP2 SFTPC, SCGB1A1, FOXP2 Development of caudate 
nucleus, cerebellum, and 
 putamen of CNS.
Motor abnormalities, absence of 
ultrasonic vocalization. Mice die by 3 
weeks after birth.
Associated with speech 
and language disorder.
FOXP3 (Xp11.23) TGFB1, Cd3, prostaglandin 
E2, CD28, cyclosporin A, Tcr, 
TGAL copolymer, PTGER4, 
CBLB, PTGER2, Flagellin, 
LEPR, PLP1, AG490, CTLA4
IL4, IL2, IL5, IL2RA, SMAD7, 
ITGAE, ERBB2, SELL, IgG2a, 
IgM, IgG1, CD40LG
Regulatory T cell development. Multiorgan inflammatory response, 
eosinophilia, dysregulated cytokine 
production, hyperimmunoglobu-
linemia E. Males die 3 weeks after 
birth.
Breast cancer supressor. 
Associated with neonatal 
diabetes, enteropathy 
and endocrinopathy.
FOXP4 (6p21.1) FOXP4 FOXP4 Heart development. 2 hearts develop, esophagus and 
trachea do not separate. Die ~E12.5.
FOXQ1 (6p25.3) flutamide, TITF1, DHT Telokin Modulates natural killer cell 
function. 
Mice have a silky coat.
FOXR1 (11q23.3)
FOXR2 (Xp11.21)
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Forkhead transcription factors were first discovered more than 10 years ago in Drosophila and are characterized by a shared 100 amino acid DNA-binding motif, 
termed the “winged helix” or “forkhead” domain. Conserved forkhead domains have been identified in eukaryotic organisms from yeast to humans. The human genome 
contains more than 40 FOX genes. The forkhead transcription factors have been shown to play diverse roles in development, metabolism, immunology, cancer, and 
cell-cycle control.  
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